GALT · Galectin Therapeutics Inc · Documents
$3.19
-0.19 (-5.62%)
At close · Oct 23
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company’s ability to continue as a going concern for a period of 12 months from the issuance date of these financial statements.”View the 10-Q filed Aug 14, 2026
Market Cap
$321.71M
Shares
100.85M
Volume · Oct 23
195.22K
Avg daily vol (3M)
303.16K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| DEF 14A | Galectin Therapeutics will ask stockholders on December 3, 2026 to elect eleven directors, increase authorized common shares from 150,000,000 to 250,000,000, reserve 3,000,000 additional shares under its 2019 Omnibus Equity Incentive Plan, and ratify Cherry Bekaert LLP as auditor. | 2026-10-13 | 2026-12-03 | |
| DEFA14A | — | 2026-10-13 | — | |
| PRE 14A | Galectin Therapeutics will hold its virtual annual meeting on December 3, 2026, seek approval to increase authorized common shares from 150,000,000 to 250,000,000 and reserve an additional 3,000,000 shares under its 2019 Omnibus Equity Incentive Plan, and elect eleven directors. | 2026-10-02 | 2026-12-03 | |
| Investor Event Transcript | — | 2026-09-14 | 2026-09-30 | |
| 10-Q | — | 2026-08-14 | 2026-06-30 | |
| 8-K | — | 2026-08-14 | — | |
| 8-K | — | 2026-08-04 | 2026-07-31 | |
| 8-K | — | 2026-06-23 | — | |
| 8-K | — | 2026-05-15 | — | |
| 10-Q | — | 2026-05-15 | 2026-03-31 | |
| 10-K | — | 2026-03-31 | 2025-12-31 | |
| S-3 | — | 2026-03-31 | — | |
| 8-K | — | 2026-03-31 | — | |
| 8-K | — | 2026-03-17 | 2026-03-12 | |
| 8-K | — | 2026-01-21 | 2026-01-16 | |
| 8-K | — | 2026-01-12 | 2026-01-10 | |
| 8-K | — | 2025-12-19 | — | |
| 8-K | — | 2025-12-08 | 2025-12-03 | |
| 8-K | — | 2025-12-03 | — | |
| 8-K | — | 2025-11-14 | — | |
| 10-Q | — | 2025-11-14 | 2025-09-30 | |
| 8-K | — | 2025-11-10 | — | |
| DEFA14A | — | 2025-10-22 | — | |
| DEF 14A | — | 2025-10-22 | 2025-12-03 | |
| 8-K | — | 2025-09-08 | — | |
| 8-K | — | 2025-08-14 | — | |
| 10-Q | — | 2025-08-14 | 2025-06-30 | |
| 8-K | — | 2025-07-09 | 2025-07-08 | |
| 8-K | — | 2025-06-16 | — | |
| 10-Q | — | 2025-05-15 | 2025-03-31 | |
| 8-K | — | 2025-05-15 | — | |
| 8-K | — | 2025-05-12 | — | |
| 8-K | — | 2025-03-31 | — | |
| 10-K | — | 2025-03-31 | 2024-12-31 | |
| 8-K | — | 2025-03-05 | — | |
| 8-K | — | 2025-02-18 | — | |
| 8-K | — | 2025-01-28 | 2025-01-23 | |
| 8-K | — | 2025-01-23 | — | |
| 8-K | — | 2025-01-13 | — | |
| 8-K | — | 2024-12-20 | — | |
| DEF 14A | — | 2024-12-03 | 2025-01-23 | |
| DEFA14A | — | 2024-12-03 | — | |
| 10-Q | — | 2024-11-14 | 2024-09-30 | |
| 8-K | — | 2024-11-14 | — | |
| 8-K | — | 2024-11-14 | — | |
| 8-K | — | 2024-09-09 | — | |
| 10-Q | — | 2024-08-13 | 2024-06-30 | |
| 8-K | — | 2024-08-13 | — | |
| 8-K | — | 2024-08-01 | 2024-07-26 | |
| 10-Q | — | 2024-05-15 | 2024-03-31 |
Showing 1–50 of 125 filings
Key facts
CIK
1133416
CUSIP
363225202
13F (30d)
15 filings
15 filers
Visit website
Investor relations